(BUSINESS WIRE)--NeuroTherapeutics Pharma, Inc., or NTP, is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system (CNS) disorders. The company is working with novel mechanisms that will generate first-in-class therapeutics, thereby changing the standard of care for patients suffering from epilepsy, neuropathic and acute pain, and other disorders of the nervous system.
